---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-25-005919"
form_type: "8-K"
ticker: "EBRCZ"
cik: "0001347123"
company_name: "EBR Systems, Inc."
filed_at: "2025-04-15T23:59:59+00:00"
generated_at: "2026-05-23T14:20:50.593725+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CMS proposes NTAP reimbursement for EBR's WiSE CRT at max 65% rate

## Summary
- CMS proposed NTAP for WiSE CRT System for FY 2026 at maximum add-on payment of 65% of device cost.
- NTAP is in addition to standard MS-DRG payment, intended to fully cover device cost.
- NTAP effective from 1 Oct 2025 for three years, subject to final CMS rule expected August 2025.
- EBR plans to apply for Transitional Pass-through reimbursement for outpatients shortly.
- FDA approval of WiSE CRT also announced; both milestones advance US commercialization.

## SEC filing metadata
- accession: 0001214659-25-005919
- form_type: 8-K
- ticker: EBRCZ
- cik: 0001347123
- company_name: EBR Systems, Inc.
- filed_at: 2025-04-15T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347123/000121465925005919/0001214659-25-005919-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347123/000121465925005919/z4152508k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-25-005919
- JSON: https://secwatch.observer/filing/0001214659-25-005919.json
- Plain text: https://secwatch.observer/filing/0001214659-25-005919.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.